alem tumuzumab with CHOP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for alem tumuzumab with CHOP, covering 2019-03-01 to 2019-03-01. Get the full timeline:
Most recent: Clinical Trial Update: Alemtuzumab and CHOP in T-cell Lymphoma [Phase 3]